Citadel Advisors’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-15,400
| Closed | -$2.1M | – | 10081 |
|
|
2018
Q2 | $2.1M | Sell |
15,400
-14,400
| -48% | -$1.31M | ﹤0.01% | 4034 |
|
|
2018
Q1 | $2.35M | Sell |
29,800
-14,600
| -33% | -$1.08M | ﹤0.01% | 3488 |
|
|
2017
Q4 | $3.03M | Buy |
44,400
+29,300
| +194% | +$1.52M | ﹤0.01% | 3080 |
|
|
2017
Q3 | $607K | Sell |
15,100
-2,800
| -16% | -$108K | ﹤0.01% | 5032 |
|
|
2017
Q2 | $712K | Buy |
17,900
+4,500
| +34% | +$165K | ﹤0.01% | 4611 |
|
|
2017
Q1 | $432K | Buy |
13,400
+1,300
| +11% | +$32.4K | ﹤0.01% | 5267 |
|
|
2016
Q4 | $214K | Buy |
12,100
+1,400
| +13% | +$30.2K | ﹤0.01% | 6217 |
|
|
2016
Q3 | $250K | Sell |
10,700
-700
| -6% | -$15.9K | ﹤0.01% | 5974 |
|
|
2016
Q2 | $213K | Buy |
11,400
+700
| +7% | +$12.7K | ﹤0.01% | 5740 |
|
|
2016
Q1 | $195K | Buy |
10,700
+7,300
| +215% | +$118K | ﹤0.01% | 5659 |
|
|
2015
Q4 | $72K | Buy |
+3,400
| New | +$65.5K | ﹤0.01% | 7007 |
|
|
2015
Q2 | – | Sell |
-15,700
| Closed | -$755K | – | 9307 |
|
|
2015
Q1 | $755K | Buy |
15,700
+9,200
| +142% | +$417K | ﹤0.01% | 4322 |
|
|
2014
Q4 | $144K | Buy |
6,500
+500
| +8% | +$11.5K | ﹤0.01% | 6329 |
|
|
2014
Q3 | $114K | Sell |
6,000
-5,200
| -46% | -$124K | ﹤0.01% | 6292 |
|
|
2014
Q2 | $302K | Buy |
11,200
+4,300
| +62% | +$109K | ﹤0.01% | 5066 |
|
|
2014
Q1 | $223K | Buy |
+6,900
| New | +$224K | ﹤0.01% | 5399 |
|
Citadel Advisors's FMI Position: Q2 2018 in Review
Citadel Advisors sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 8,391 shares — an estimated $762K sold.
Citadel Advisors first reported a position in FMI in Q3 2013 and held it in 10 quarters. The position peaked at $20.9M in Q3 2013. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.
- Citadel Advisors reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
- Citadel Advisors sold 8,391 Foundation Medicine, Inc. shares in Q2 2018, an estimated $762K.
- Citadel Advisors first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 10 quarters.
- Citadel Advisors's Foundation Medicine, Inc. position peaked at $20.9M in Q3 2013.
- 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.